Abstract
Objective: The key objective of the study is to compare the Propofol-based total intravenous anaesthesia (TIVA) with Isoflurane-based inhalational anaesthesia for controlled hypotension during functional endoscopic sinus surgery (FESS). Materials and Methods: This is a prospective randomized, controlled single-blinded clinical study. The study involved 40 patients posted for elective FESS surgery, selected randomly from the ENT department. Anesthesia was induced with Inj. Midazolam 2 mg, Inj. Fentanyl 2 µg/kg, Inj. Propofol 2 mg/kg, Inj. Vecuronium 0.1 mg /kg and ventilated using oxygen, air, and Isoflurane (FiO2 of 0.5) in isofurane group patients. Injections of 2 mg of midazolam, 2 µg/kg of fentanyl, 2 mg/kg propofol, and 0.1 mg /kg vecuronium, as well as oxygen and air for ventilation, were used to induce anaesthesia (FIO2 of 0.5) in TIVA group patients. Fromme boezaart scale was used as an evaluation scale for surgical site bleeding. Results: The average blood loss in the isoflurane group was 134.25 ± 4.65ml and in the propofol group was 66.95 ± 4.28ml. The quality of the surgical field in the propofol group is (3.13 ± 0.9), and the isoflurane group is (3.13 ± 0.8). The results are significant. Conclusion: Total intravenous anesthesia using propofol provides notable advantages over the traditionally used inhalational anesthetic technique using isoflurane in surgical field conditions and intraoperative blood loss.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Asian Journal of Pharmaceutical and Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.